Facet browsing currently unavailable
Page 1 of 3575223 results
Sort by: relevance publication year
Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19) JOURNAL ARTICLE published 20 May 2020 in Indonesian Journal of Cardiology |
Managing QT prolongation in the Era of Coronavirus Disease 2019 (COVID-19) JOURNAL ARTICLE published 20 May 2020 in Indonesian Journal of Cardiology |
Remdesivir induced bradycardia and QT prolongation: A rare side effect of a ubiquitous drug of the COVID -19 era JOURNAL ARTICLE published 2022 in Journal of Anaesthesiology Clinical Pharmacology |
Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir JOURNAL ARTICLE published 1 October 2022 in YAKUGAKU ZASSHI |
No improvement in mortality rates for COVID-19 patients treated with remdesivir JOURNAL ARTICLE published 2020 in Pharmaceutical Journal |
Obinutuzumab/remdesivir/tozinameran JOURNAL ARTICLE published 18 March 2023 in Reactions Weekly |
Using Mendelian randomization to unveil the truth: does COVID-19 impact QT interval prolongation? POSTED CONTENT published |
Counterbalancing the Hydroxychloroquine Induced QT Prolongation: COVID 19 and Beyond POSTED CONTENT published |
Reply to: “QT Prolongation With Hydroxychloroquine and Azithromycin For The Treatment of COVID-19: The Need For Pharmacogenetic Insights” POSTED CONTENT published |
Remdesivir Related QT Prolongation Resulting in Cardiac Arrest PROCEEDINGS ARTICLE published May 2023 in B48. TOXICOLOGY AND OTHER MEDICATIONS IN THE ICU: CASE REPORTS |
QT Interval Prolongation in Patients Treated for COVID-19 POSTED CONTENT published |
EVALUATION OF QT/QTC INTERVAL PROLONGATION IN COVID-19 PATIENTS RECEIVED HYDROXYCHLOROQUINE (HCQ) JOURNAL ARTICLE published 1 March 2021 in International Journal of Biology, Pharmacy and Allied Sciences |
Clinical update of medications associated with QT prolongation among COVID-19 patients JOURNAL ARTICLE published 4 September 2022 in The European Research Journal Research funded by N/A (N/A) |
QT Prolongation REFERENCE ENTRY published in SpringerReference |
Use of drugs associated with QT interval prolongation at the hospital level during the start of the COVID-19 pandemic in Colombia v2 POSTED CONTENT published |
Outcome of Remdesivir on Mortality in Patients with COVID-19 Pneumonia POSTED CONTENT published |
Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: A historical cohort study POSTED CONTENT published |
CORONAVIRUS DISEASE (COVID-19) TREATMENT ALGORITHMS IN PATIENTS WITH QT INTERVAL PROLONGATION JOURNAL ARTICLE published 2020 in Journal of the Grodno State Medical University |
An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine JOURNAL ARTICLE published May 2020 in HeartRhythm Case Reports |
QT interval prolongation is a novel predictor of one year morality in patients with coronavirus disease-19 infection JOURNAL ARTICLE published 19 May 2022 in EP Europace |